HIP Surgery - Hemodynamic Optimization Project (HipHop)

Charité University Medicine Berlin

Status: Unknown

Conditions: Redo Hip Surgery

Treatments: Device: Stroke volume monitoring

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01753050

HipHop

EA1/315/12 (Other Identifier)

Details and patient eligibility

About

Several studies have demonstrated that goal-directed fluid therapy during high- risk-surgery reduces morbidity and length of hospital stay. This quality improvement is design to evaluate the implementation of an intraoperative goal-directed therapy, using a pulse contour analysis monitor to optimize the stroke volume, in patients undergoing redo-hip-surgery. The primary combined endpoints will be the incidence of postoperative complications and the secondary endpoints will be the decrease of hospital length of stay, length of ICU stay and hospital postoperative mortality. We amended another 130 patients getting crystalloid fluids in the hemodynamic optimization protocol.

Enrollment: 390 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients undergoing redo hip surgery
• age above 18 years
• signed informed consent

Exclusion criteria

• urgent or emergency surgery

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

390 participants in 2 patient groups

Standard care

No Intervention group

Description:

No specific hemodynamic optimization measures

Hemodynamic optimization

Experimental group

Description:

Hemodynamic optimization by stroke volume monitoring

Treatment:

Device: Stroke volume monitoring